Will Morgan Levine start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
7
180Ṁ662028
54%
chance
1H
6H
1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Market context
Get 
1,000 to start trading!
1,000People are also trading
Related questions
Will GLP-1 agonists help stop or reverse the US obesity trend by end of 2027
86% chance
Will Mike Lustgarten start to regularly ANY of {rapamycin, metformin, acarbose, SGLT2 inhibitors) by the end of 2027?
58% chance
Will ANY of {metformin, canagliflozin, acarbose, rapamycin} be made OTC to purchase in US by Jan2028?
48% chance
Will Jose Luis ricon finally start regularly taking rapamycin by 2030?
45% chance
Will Peter Thiel start regularly taking rapamycin by EOY 2027?
35% chance
Will jurgen schmidhuber end up taking rapamycin by EOY 2028
41% chance
Will a majority government owned company introduce a new GLP-1 drug before 2040?
15% chance
Will a senolytic drug be used clinically for any purpose by the end of 2028?
50% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will a GLP-1 agonist diabetes / weight loss drug be the top bestselling drug in 2025?
30% chance